{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T07:40:04Z","timestamp":1756366804132,"version":"3.44.0"},"reference-count":15,"publisher":"BMJ","issue":"12","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2021,11,25]]},"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:p>Evans syndrome (ES) is a simultaneous or subsequent development of two haematological disorders, autoimmune haemolytic anaemia (AIHA) and immune thrombocytopenia (ITP). It can be primary (idiopathic) or secondary (associated with an underlying disease). Primary Evans is a diagnosis of exclusion and has a poorer prognosis than AIHA or ITP alone. We present a 55-year-old man who presented with weakness and lethargy and was diagnosed to be suffering from primary ES.<\/jats:p>","DOI":"10.1136\/bcr-2021-243051","type":"journal-article","created":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T11:35:38Z","timestamp":1639049738000},"page":"e243051","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Primary Evans syndrome in an adult man"],"prefix":"10.1136","volume":"14","author":[{"given":"Archita","family":"Makharia","sequence":"first","affiliation":[{"name":"General Medicine, Dr Sampurnanand Medical College, Jodhpur, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manoj","family":"Lakhotia","sequence":"additional","affiliation":[{"name":"General Medicine, Dr Sampurnanand Medical College, Jodhpur, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brateen","family":"Roy","sequence":"additional","affiliation":[{"name":"General Medicine, Dr Sampurnanand Medical College, Jodhpur, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2021,12,9]]},"reference":[{"key":"2025082800013768000_14.12.e243051.1","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.3390\/jcm9123851","article-title":"Evans\u2019 Syndrome: From Diagnosis to Treatment","volume":"9","author":"Audia","year":"2020","journal-title":"J Clin Med"},{"key":"2025082800013768000_14.12.e243051.2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-06-583021"},{"key":"2025082800013768000_14.12.e243051.3","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-04-215368"},{"key":"2025082800013768000_14.12.e243051.4","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3389\/fped.2015.00079","article-title":"Evans Syndrome in Children: Long-Term Outcome in a Prospective French National Observational Cohort","volume":"3","author":"Aladjidi","year":"2015","journal-title":"Front Pediatr"},{"key":"2025082800013768000_14.12.e243051.5","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1002\/ajh.25574","article-title":"Evans syndrome in adults - incidence, prevalence, and survival in a nationwide cohort","volume":"94","author":"Hansen","year":"2019","journal-title":"Am J Hematol"},{"key":"2025082800013768000_14.12.e243051.6","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2147\/JBM.S176144","article-title":"Evans syndrome: clinical perspectives, biological insights and treatment modalities","volume":"9","author":"Jaime-P\u00e9rez","year":"2018","journal-title":"J Blood Med"},{"key":"2025082800013768000_14.12.e243051.7","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1182\/blood.2019003812","article-title":"How I treat paroxysmal nocturnal hemoglobinuria","volume":"137","author":"Brodsky","year":"2021","journal-title":"Blood"},{"key":"2025082800013768000_14.12.e243051.8","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1182\/blood-2020-136900","article-title":"Evans\u2019 Syndrome in Adults: An Observational Multicentre Study","volume":"136","author":"Fattizzo","year":"2020","journal-title":"Blood"},{"key":"2025082800013768000_14.12.e243051.9","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.3390\/jcm9123859","article-title":"New Insights in Autoimmune Hemolytic Anemia: From Pathogenesis to Therapy Stage 1","volume":"9","author":"Barcellini","year":"2020","journal-title":"J Clin Med"},{"key":"2025082800013768000_14.12.e243051.10","doi-asserted-by":"crossref","unstructured":"Barcellini W , Fattizzo B . Clinical Applications of Haemolytic Markers in theDifferential Diagnosis and Management of Haemolytic Anaemia. Dis Markers2015 2015;635670.","DOI":"10.1155\/2015\/635670"},{"key":"2025082800013768000_14.12.e243051.11","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12541"},{"key":"2025082800013768000_14.12.e243051.12","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/ajh.24570","article-title":"A randomized and double-blind controlled trial evaluating the safety and efficacy of rituximab for warm auto-immune hemolytic anemia in adults (the RAIHA study)","volume":"92","author":"Michel","year":"2017","journal-title":"Am J Hematol"},{"key":"2025082800013768000_14.12.e243051.13","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1182\/blood.2019003808","article-title":"How I treat warm autoimmune hemolytic anemia","volume":"137","author":"Barcellini","year":"2021","journal-title":"Blood"},{"key":"2025082800013768000_14.12.e243051.14","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2019.100648","article-title":"Diagnosis and treatment of autoimmune hemolytic anemia in adults: Recommendations from the First International Consensus Meeting","volume":"41","author":"J\u00e4ger","year":"2020","journal-title":"Blood Rev"},{"key":"2025082800013768000_14.12.e243051.15","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1182\/bloodadvances.2019000812","article-title":"Updated international consensus report on the investigation and management of primary immune thrombocytopenia","volume":"3","author":"Provan","year":"2019","journal-title":"Blood Adv"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2021-243051","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T07:01:42Z","timestamp":1756364502000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2021-243051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":15,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2021,12,9]]},"published-print":{"date-parts":[[2021,12]]}},"alternative-id":["10.1136\/bcr-2021-243051"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2021-243051","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2021,12]]}}}